New clinical trial seeks a regenerative pharmaceutical solution for meniscal tears

FHS
July 10, 2023
11:40 pm

With support from Amplicore, a University of Cincinnati spinoff biopharmaceutical company, researchers at UC have begun a Department of Defense-funded clinical trial that seeks a regenerative pharmaceutical solution for meniscal tears.

Research reveals transgenerational effects of adversity on the human gut microbiome

Hardship experienced by mothers during their own childhood or during pregnancy is reflected in the composition of their 2-year-old children’s gut microbiomes, reports an international

July 21, 2023

Lung Function Stable in Sickle Cell Patients After Non-Myeloablative Transplant

Pulmonary function remained stable — and in some ways improved — among patients with sickle cell disease (SCD) who underwent non-myeloablative hematopoietic cell transplant (HCT),

August 29, 2024

Biomarker Predicts Colon Cancer Risk in Ulcerative Colitis

Testing for somatic genomic copy number alterations (CNAs) in ulcerative colitis patients with low-grade dysplasia was able to predict risk of advanced neoplasia more accurately

February 1, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.